Standard SPAC S-1/A filing with no target identified. Monitor for future 8-K filings for trust account balance and any definitive agreement announcements for a business combination target. Stock will trade based on management credibility and sector focus (tech/healthcare/logistics) rather than fundamentals. No catalyst until a target is announced.
Executive Summary
JAB Acquisition Corp I filed Amendment No. 1 to its S-1 registration statement for a SPAC IPO, updating the filing date to May 29, 2026. The company is offering 15,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share, one warrant (exercise price $11.50), and one right to receive 1/4 of a Class A ordinary share upon a business combination. The underwriters have a 45-day option for up to 2,250,000 additional units. The sponsor is purchasing 260,000 private units simultaneously. Proceeds of $150M (or $172.5M with over-allotment) will be placed in a trust account; the company has 12 months to complete a business combination, extendable by up to two three-month periods. This is a standard SPAC IPO filing with no material changes from the initial S-1.
Key Financial Metrics
Key Facts
- Offering 15,000,000 units at $10.00 per unit for gross proceeds of $150M.
- Each unit: 1 Class A ordinary share + 1 warrant ($11.50 exercise) + 1 right (1/4 share upon business combination).
- Underwriters have 45-day option for up to 2,250,000 additional units.
- Sponsor committed to purchase 260,000 private units at $10.00 each ($2.6M total).
- Net proceeds of $150M (or $172.5M with over-allotment) placed in trust account.
- 12-month window to complete initial business combination, extendable by up to two 3-month periods with $0.10/share deposit.
- No target selected; no substantive discussions initiated with any target.
- Focus on technology, healthcare, and logistics industries; seeking enterprise value of $200M or greater.
- Founder shares: 9,857,143 Class B shares issued to sponsor for $25,000 ($0.002/share); up to 1,285,714 subject to forfeiture based on over-allotment exercise.
- Representative shares: 1,000,000 Class A ordinary shares to D. Boral Capital as underwriting compensation.
Financial Impact
Gross proceeds of $150M from public offering plus $2.6M from private placement sponsor units, totaling $152.6M. Trust account will hold $150M ($10.00 per public share).
Risk Factors
- No target selected; risk of liquidation if no business combination completed within 12-18 months.
- Substantial dilution from founder shares purchased at $0.002/share vs. public offering price of $10.00/unit.
- Sponsor and management may have conflicts of interest in selecting a target.
- Ability to complete business combination may be affected by redemptions and market conditions.
- Warrants and rights will expire worthless if no business combination completed.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001213900-26-062789 |
| Document: ea028589903ex3-2.htm | 0001213900-26-062789 |
| Document: ea028589903ex1-1.htm | 0001213900-26-062789 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 12w ago | 8-K | — | awaiting T+20 | — | — |
Jun 12, 2026 19w ago | 8-K | — | awaiting T+20 | — | — |
Jun 10, 2026 19w ago | 424B4 | — | awaiting T+20 | — | — |
Jun 10, 2026 19w ago | EFFECT | — | awaiting T+20 | — | — |
Jun 9, 2026 20w ago | 3 | — | awaiting T+20 | — | — |
Jun 9, 2026 20w ago | 3 | — | awaiting T+20 | — | — |
Jun 5, 2026 20w ago | S-1/A | — | awaiting T+20 | — | — |
Jun 5, 2026 20w ago | S-1/A | — | awaiting T+20 | — | — |
May 29, 2026 21w ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers